TXG · Healthcare
10x Genomics Inc
26/100
Smart-money confidence1 of 3 sources positive
Below average interest
company insiders are selling
What this band has actually done: stocks scoring 0–25 beat the S&P 500 over the next three months 39.9% of the time, across 100,496 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this
Hedge funds
51
Congress
No data
Insiders
0
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$11.5B
Industry
Medical Devices
Sector
Healthcare
Exchange
NasdaqGS
About 10X GENOMICS INC
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses…
Who's behind the signal
Every informed buyer we can see on TXG, across all three feeds.
Hedge funds · 10
Duquesne Family Office (Druckenmiller)
New position
Point72 (Steve Cohen)
New position
Citadel Advisors
Increased +274%
D.E. Shaw & Co
Increased +240%
ARK Invest (Cathie Wood)
Decreased −15%
Renaissance Technologies
Decreased −20%
+4 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
Company insiders
Selling
Recent sells28
Not a model pick — but on our radar.
10X GENOMICS INC isn't in the top-10 model right now, but 10 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
10
Investors
2
New positions
2
Increasing
6
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.6×
% of portfolio
0.3%
Position change
NEW
0.3% of Duquesne Family Office's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
NEW
0.1% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+274%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+240%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.3×
% of portfolio
2.5%
Position change
−15%
2.5% of ARK Invest's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−20%
0.0% of Renaissance Technologies's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−20%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
−4%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−62%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−94%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to 10X GENOMICS INC
Insider Trading (Form 4)
Recent trades by company officers and directors — filed within 2 days of each trade
Bearish
Sentiment
0
Buys
28
Sells
| Date | Insider | Title | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-22 | Saxonov Serge | Insider | SELL | 2,800 | $82.36 | $230,622 |
| 2026-09-22 | Saxonov Serge | Insider | SELL | 9,900 | $81.83 | $810,071 |
| 2026-09-22 | Saxonov Serge | Insider | SELL | 9,300 | $80.90 | $752,401 |
| 2026-09-22 | Saxonov Serge | Insider | SELL | 2,000 | $79.62 | $159,239 |
| 2026-09-22 | Saxonov Serge | Insider | SELL | 1,000 | $78.23 | $78,228 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Insider | SELL | 1,222 | $82.28 | $100,542 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Insider | SELL | 2,270 | $81.67 | $185,391 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Insider | SELL | 1,325 | $80.82 | $107,082 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Insider | SELL | 614 | $79.51 | $48,820 |
| 2026-09-22 | SULIMAN SHEHNAAZ | Insider | SELL | 292 | $78.20 | $22,833 |
| 2026-09-09 | Taich Adam | Insider | SELL | 13,754 | $65.26 | $897,550 |
| 2026-09-09 | Taich Adam | Insider | SELL | 31,428 | $64.31 | $2,021,125 |
| 2026-09-09 | Taich Adam | Insider | SELL | 1,206 | $63.68 | $76,795 |
| 2026-09-03 | STUELPNAGEL JOHN R | Insider | SELL | 6,174 | $62.61 | $386,533 |
| 2026-09-03 | STUELPNAGEL JOHN R | Insider | SELL | 6,814 | $62.11 | $423,205 |
| 2026-09-03 | STUELPNAGEL JOHN R | Insider | SELL | 7,012 | $60.66 | $425,333 |
| 2026-08-26 | Saxonov Serge | Insider | SELL | 492 | $64.75 | $31,855 |
| 2026-08-26 | Saxonov Serge | Insider | SELL | 6,494 | $63.98 | $415,465 |
| 2026-08-26 | Saxonov Serge | Insider | SELL | 3,500 | $63.02 | $220,580 |
| 2026-08-24 | Saxonov Serge | Insider | SELL | 18,545 | $63.02 | $1,168,775 |
Showing the 20 most recent of 28 buys & sells.
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell 10X GENOMICS INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime